✦ LIBER ✦

Reaching C-Reactive Protein and Low-Density Lipoprotein Cholesterol Goals in Dyslipidemic Patients (from the Lipid Treatment Assessment Project [L-TAP] 2)

✍ Scribed by Cheng-Wen Chiang; Raul D. Santos; David D. Waters; Michael Messig; Lisa Tarasenko; J. Wouter Jukema; Jean Ferrières; JoAnne Foody; Ki-Bae Seung

Book ID: 113447966
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 370 KB
Volume: 107
Category: Article
ISSN: 0002-9149
DOI: 10.1016/j.amjcard.2011.01.050

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low- and high-density lipoprotein choles

Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2

✍ Raul D. Santos; David D. Waters; Lisa Tarasenko; Michael Messig; J. Wouter Jukem 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 391 KB

Comparison of Lipid Profiles and Attainm

Comparison of Lipid Profiles and Attainment of Lipid Goals in Patients <65 Years Versus Patients ≥65 Years (from the Lipid Treatment Assessment Project [L-TAP] 2)

✍ Fatima Rodriguez; Raul D. Santos; Michael Messig; Lisa Tarasenko; Jean Ferrières 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Comparison of Effectiveness of Rosuvasta

Comparison of Effectiveness of Rosuvastatin Versus Atorvastatin on the Achievement of Combined C-Reactive Protein (<2 mg/L) and Low-Density Lipoprotein Cholesterol (<70 mg/dl) Targets in Patients With Type 2 Diabetes Mellitus (from the ANDROMEDA Study)

✍ D. John Betteridge; J. Martin Gibson; Philip T. Sager 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Relative Efficacy of Atorvastatin 80 mg

Relative Efficacy of Atorvastatin 80 mg and Pravastatin 40 mg in Achieving the Dual Goals of Low-Density Lipoprotein Cholesterol <70 mg/dl and C-Reactive Protein <2 mg/l. An Analysis of the PROVE-IT TIMI-22 Trial

✍ P.M. Ridker; D.A. Morrow; L.M. Rose 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 35 KB